Japan· JP-2411400D2029
テトラコサクチド酢酸塩
A medicinal product containing テトラコサクチド酢酸塩, registered in Japan by アルフレッサファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- テトラコサクチド酢酸塩
- Manufacturer
- アルフレッサファーマ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
テトラコサクチド酢酸塩 in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCortrosynHenry Schein, Inc.
- United KingdomSynacthen 250micrograms/1ml solution for injection ampoulesAtnahs Pharma UK Ltd
- CanadaCORTROSYN INJ 0.25MGAMPHASTAR PHARMACEUTICALS, INC.
- NorwaySynacthenAlfasigma S.p.A
- SpainNUVACTHEN DEPOT 1MG/ML SUSPENSIÓN INYECTABLEAlfasigma S.P.A.
- SwedenSynacthen 0,25 mg/ml Injektions-/infusionsvätska, lösningAlfasigma S.P.A.
- SwitzerlandSynacthen, InjektionslösungAtnahs Pharma Switzerland AG
- NetherlandsSynacthen 0,25 mg/ml, oplossing voor injectie of infusieAlfasigma S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Synacthen Ampulle, Synacthen Depot
- Belgium · Synacthen, Synacthen Depot
- Denmark · Synacthen
- France · Synacthene, Synacthene Retard
- Ireland · Synacthen
- Italy · Synacthen
- Luxembourg · Synacthen, Synacthen Dépôt
- Netherlands · Synacthen
- Sweden · Synacthen, Synacthen Depot
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/34e75584-2625-417b-97e3-dc0fafe3f234 GET /v1/drugs/34e75584-2625-417b-97e3-dc0fafe3f234?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．２５ｍｇ１瓶（溶解液付）",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2411400D2029",
"category": "注射薬",
"price_yen": 2963,
"generic_name": "テトラコサクチド酢酸塩",
"product_name_jp": null,
"therapeutic_class": "2411",
"transitional_expiry": null
}See everything about テトラコサクチド酢酸塩.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.